GENEXUS Trademark

Trademark Overview

On Tuesday, March 19, 2024, a trademark application was filed for GENEXUS with the United States Patent and Trademark Office. The USPTO has given the GENEXUS trademark a serial number of 98456967. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Wednesday, September 10, 2025. This trademark is owned by Life Technologies Corporation. The GENEXUS trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical use
genexus

General Information

Serial Number98456967
Word MarkGENEXUS
Filing DateTuesday, March 19, 2024
Status760 - EX PARTE APPEAL PENDING
Status DateWednesday, September 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic preparations for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLife Technologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 6, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 19, 2024NEW APPLICATION ENTERED
Sunday, June 30, 2024ASSIGNED TO EXAMINER
Tuesday, August 6, 2024NON-FINAL ACTION E-MAILED
Tuesday, August 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, February 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 6, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, February 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 10, 2025FINAL REFUSAL WRITTEN
Tuesday, June 10, 2025FINAL REFUSAL E-MAILED
Tuesday, June 10, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 23, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 23, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 10, 2025EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, September 10, 2025EX PARTE APPEAL-INSTITUTED
Tuesday, September 16, 2025ASSIGNED TO LIE
Wednesday, September 10, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, September 10, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED

Related Keywords

genexus medical preparations diagnostic